Trefoil Therapeutics Secures $28M Series A Round San Diego biotech Trefoil Therapeutics recently brought in a $28 million series A round for work on vision diseases. Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment Name * Email * Website